[Intravascular decompressive aerogenesis ultrasonography in a practice of diving medical physician].

The aim of research was substantiation of necessity and accessibility of acoustic indication of intravascular decompressive aerogenesis in a practice of diving medical. Authors define possibilities of portable ultrasound blood flow indicator for location of decompressive gas bubbles. It was found that acoustic indication of intravascular decompressive gas bubbles made by simple portable ultrasonic blood flow meter allows to reveal moving gas bubble in blood flow. Authors came to conclusion that it is necessary to include portable ultrasonic diagnostic equipment into the norms of medical supply for ships, vessels and military units of the Armed Forces of the Russian Federation.

[Determination of divers' resistance to decompression gas formation].

The aim of the study was to determine the correlation between the state of the individual functions of the organism and the intensity of decompression venous gas embolism after high air pressure exposure. The analysis of the guidelines defining the procedure of divers' medical examination was made and 320 divers were surveyed. Indices of the divers' central nervous and cardiovascular systems were measured before and after their immersion into a hyperbaric chamber. The study found that the conduct divers' on-resistance to unfavorable scuba dive should be provided by the military-medical commission, so the position of diving doctor should be put to it staff. It was revealed that the rate of simple visual-motor reaction, measured before the diving can serve as an indicator of human resistance to decompression gassing. The formula for determining the stability of decompression gassing of men aged 20-30 years in terms of state of organism functions was proposed.

[Using metabolic cytoprotector Remaxol for urgently increased stability towards acute decompression syndrome].

The article deals with evaluation of efficiency of metabolic cytoprotector Remaxol as a medication for urgently increased stability towards acute decompression syndrome at severe degree, studied in experiments on 45 outbred male rabbits. Single intravenous injection of Remaxol relieves oxidant effects of inadequate decompression, lowers number of lethal outcomes due to acute decompression syndrome, increases survival time in the animals.